APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Glycoprotein 41

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Glycoprotein 41 Industry Growth and Trends Forecast to 2032

Report ID 173995950126 December 202596 pages

Choose your research edition.

Industry ResearchGlycoprotein 41 Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Glycoprotein 41 Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Glycoprotein 41 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glycoprotein 41 Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Glycoprotein 41 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Glycoprotein 41 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glycoprotein 41 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glycoprotein 41 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glycoprotein 41 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glycoprotein 41 include Amunix Operating Inc, Frontier Biotechnologies Inc, InnaVirVax SA, Longevity Biotech Inc, Mymetics Corp, Navigen Inc, Osel Inc and Pharis Biotec GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glycoprotein 41 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glycoprotein 41 market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glycoprotein 41 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glycoprotein 41.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glycoprotein 41 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glycoprotein 41 Market by Company

Amunix Operating Inc

Frontier Biotechnologies Inc

InnaVirVax SA

Longevity Biotech Inc

Mymetics Corp

Navigen Inc

Osel Inc

Pharis Biotec GmbH

Glycoprotein 41 Segment by Type

DS-007

LBT-5001

LBT-5001

MYMV-101

Others

Glycoprotein 41 Segment by Application

Hospital

Clinic

Others

Glycoprotein 41 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycoprotein 41 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glycoprotein 41 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycoprotein 41.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glycoprotein 41 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glycoprotein 41 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of DS-007 Table 2. Major Company of LBT-5001 Table 3. Major Company of LBT-5001 Table 4. Major Company of MYMV-101 Table 5. Major Company of Others Table 6. Global Glycoprotein 41 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Glycoprotein 41 Sales by Type (2021-2026) & (W Units) Table 8. Global Glycoprotein 41 Sales Market Share in Volume by Type (2021-2026) Table 9. Global Glycoprotein 41 Sales by Type (2021-2026) & (US$ Million) Table 10. Global Glycoprotein 41 Sales Market Share in Value by Type (2021-2026) Table 11. Global Glycoprotein 41 Price by Type (2021-2026) & (US$/Unit) Table 12. Global Glycoprotein 41 Sales by Type (2027-2032) & (W Units) Table 13. Global Glycoprotein 41 Sales Market Share in Volume by Type (2027-2032) Table 14. Global Glycoprotein 41 Sales by Type (2027-2032) & (US$ Million) Table 15. Global Glycoprotein 41 Sales Market Share in Value by Type (2027-2032) Table 16. Global Glycoprotein 41 Price by Type (2027-2032) & (US$/Unit) Table 17. North America Glycoprotein 41 Sales by Type (2021-2026) & (W Units) Table 18. North America Glycoprotein 41 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Glycoprotein 41 Sales by Type (2021-2026) & (W Units) Table 20. Europe Glycoprotein 41 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Glycoprotein 41 Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Glycoprotein 41 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Glycoprotein 41 Sales by Type (2021-2026) & (W Units) Table 24. Latin America Glycoprotein 41 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Glycoprotein 41 Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Glycoprotein 41 Sales by Type (2021-2026) & (US$ Million) Table 27. Glycoprotein 41 Industry Trends Table 28. Glycoprotein 41 Industry Drivers Table 29. Glycoprotein 41 Industry Opportunities and Challenges Table 30. Glycoprotein 41 Industry Restraints Table 31. Global Glycoprotein 41 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Glycoprotein 41 Revenue Market Share by Company (2021-2026) Table 33. Global Glycoprotein 41 Sales by Company (2021-2026) & (W Units) Table 34. Global Glycoprotein 41 Sales Share by Company (2021-2026) Table 35. Global Glycoprotein 41 Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Glycoprotein 41 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Glycoprotein 41 Major Company Production Sites and Headquarters Table 38. Global Glycoprotein 41 Company, Product Type & Application Table 39. Global Glycoprotein 41 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Glycoprotein 41 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Glycoprotein 41 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Glycoprotein 41 Sales by Region (2021-2026) & (W Units) Table 44. Global Glycoprotein 41 Sales Market Share in Volume by Region (2021-2026) Table 45. Global Glycoprotein 41 Sales by Region (2021-2026) & (US$ Million) Table 46. Global Glycoprotein 41 Sales Market Share in Value by Region (2021-2026) Table 47. Global Glycoprotein 41 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Glycoprotein 41 Sales by Region (2027-2032) & (W Units) Table 49. Global Glycoprotein 41 Sales Market Share in Volume by Region (2027-2032) Table 50. Global Glycoprotein 41 Sales by Region (2027-2032) & (US$ Million) Table 51. Global Glycoprotein 41 Sales Market Share in Value by Region (2027-2032) Table 52. Global Glycoprotein 41 Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Glycoprotein 41 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Glycoprotein 41 Sales by Application (2021-2026) & (W Units) Table 55. Global Glycoprotein 41 Sales Market Share in Volume by Application (2021-2026) Table 56. Global Glycoprotein 41 Sales by Application (2021-2026) & (US$ Million) Table 57. Global Glycoprotein 41 Sales Market Share in Value by Application (2021-2026) Table 58. Global Glycoprotein 41 Price by Application (2021-2026) & (US$/Unit) Table 59. Global Glycoprotein 41 Sales by Application (2027-2032) & (W Units) Table 60. Global Glycoprotein 41 Sales Market Share in Volume by Application (2027-2032) Table 61. Global Glycoprotein 41 Sales by Application (2027-2032) & (US$ Million) Table 62. Global Glycoprotein 41 Sales Market Share in Value by Application (2027-2032) Table 63. Global Glycoprotein 41 Price by Application (2027-2032) & (US$/Unit) Table 64. North America Glycoprotein 41 Sales by Application (2021-2026) & (W Units) Table 65. North America Glycoprotein 41 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Glycoprotein 41 Sales by Application (2021-2026) & (W Units) Table 67. Europe Glycoprotein 41 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Glycoprotein 41 Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Glycoprotein 41 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Glycoprotein 41 Sales by Application (2021-2026) & (W Units) Table 71. Latin America Glycoprotein 41 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Glycoprotein 41 Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Glycoprotein 41 Sales by Application (2021-2026) & (US$ Million) Table 74. Amunix Operating Inc Company Information Table 75. Amunix Operating Inc Business Overview Table 76. Amunix Operating Inc Glycoprotein 41 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Amunix Operating Inc Glycoprotein 41 Product Portfolio Table 78. Amunix Operating Inc Recent Development Table 79. Frontier Biotechnologies Inc Company Information Table 80. Frontier Biotechnologies Inc Business Overview Table 81. Frontier Biotechnologies Inc Glycoprotein 41 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Frontier Biotechnologies Inc Glycoprotein 41 Product Portfolio Table 83. Frontier Biotechnologies Inc Recent Development Table 84. InnaVirVax SA Company Information Table 85. InnaVirVax SA Business Overview Table 86. InnaVirVax SA Glycoprotein 41 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. InnaVirVax SA Glycoprotein 41 Product Portfolio Table 88. InnaVirVax SA Recent Development Table 89. Longevity Biotech Inc Company Information Table 90. Longevity Biotech Inc Business Overview Table 91. Longevity Biotech Inc Glycoprotein 41 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Longevity Biotech Inc Glycoprotein 41 Product Portfolio Table 93. Longevity Biotech Inc Recent Development Table 94. Mymetics Corp Company Information Table 95. Mymetics Corp Business Overview Table 96. Mymetics Corp Glycoprotein 41 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Mymetics Corp Glycoprotein 41 Product Portfolio Table 98. Mymetics Corp Recent Development Table 99. Navigen Inc Company Information Table 100. Navigen Inc Business Overview Table 101. Navigen Inc Glycoprotein 41 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Navigen Inc Glycoprotein 41 Product Portfolio Table 103. Navigen Inc Recent Development Table 104. Osel Inc Company Information Table 105. Osel Inc Business Overview Table 106. Osel Inc Glycoprotein 41 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Osel Inc Glycoprotein 41 Product Portfolio Table 108. Osel Inc Recent Development Table 109. Pharis Biotec GmbH Company Information Table 110. Pharis Biotec GmbH Business Overview Table 111. Pharis Biotec GmbH Glycoprotein 41 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Pharis Biotec GmbH Glycoprotein 41 Product Portfolio Table 113. Pharis Biotec GmbH Recent Development Table 114. North America Glycoprotein 41 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 115. North America Glycoprotein 41 Sales by Country (2021-2026) & (W Units) Table 116. North America Glycoprotein 41 Sales Market Share by Country (2021-2026) Table 117. North America Glycoprotein 41 Sales Forecast by Country (2027-2032) & (W Units) Table 118. North America Glycoprotein 41 Sales Market Share Forecast by Country (2027-2032) Table 119. North America Glycoprotein 41 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. North America Glycoprotein 41 Market Size by Country (2021-2026) & (US$ Million) Table 121. North America Glycoprotein 41 Market Share by Country (2021-2026) Table 122. North America Glycoprotein 41 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. North America Glycoprotein 41 Market Share Forecast by Country (2027-2032) Table 124. Europe Glycoprotein 41 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 125. Europe Glycoprotein 41 Sales by Country (2021-2026) & (W Units) Table 126. Europe Glycoprotein 41 Sales Market Share by Country (2021-2026) Table 127. Europe Glycoprotein 41 Sales Forecast by Country (2027-2032) & (W Units) Table 128. Europe Glycoprotein 41 Sales Market Share Forecast by Country (2027-2032) Table 129. Europe Glycoprotein 41 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Europe Glycoprotein 41 Market Size by Country (2021-2026) & (US$ Million) Table 131. Europe Glycoprotein 41 Market Share by Country (2021-2026) Table 132. Europe Glycoprotein 41 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Europe Glycoprotein 41 Market Share Forecast by Country (2027-2032) Table 134. Asia-Pacific Glycoprotein 41 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 135. Asia-Pacific Glycoprotein 41 Sales by Country (2021-2026) & (W Units) Table 136. Asia-Pacific Glycoprotein 41 Sales Market Share by Country (2021-2026) Table 137. Asia-Pacific Glycoprotein 41 Sales Forecast by Country (2027-2032) & (W Units) Table 138. Asia-Pacific Glycoprotein 41 Sales Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Glycoprotein 41 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Glycoprotein 41 Market Size by Country (2021-2026) & (US$ Million) Table 141. Asia-Pacific Glycoprotein 41 Market Share by Country (2021-2026) Table 142. Asia-Pacific Glycoprotein 41 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Asia-Pacific Glycoprotein 41 Market Share Forecast by Country (2027-2032) Table 144. Latin America Glycoprotein 41 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 145. Latin America Glycoprotein 41 Sales by Country (2021-2026) & (W Units) Table 146. Latin America Glycoprotein 41 Sales Market Share by Country (2021-2026) Table 147. Latin America Glycoprotein 41 Sales Forecast by Country (2027-2032) & (W Units) Table 148. Latin America Glycoprotein 41 Sales Market Share Forecast by Country (2027-2032) Table 149. Latin America Glycoprotein 41 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Latin America Glycoprotein 41 Market Size by Country (2021-2026) & (US$ Million) Table 151. Latin America Glycoprotein 41 Market Share by Country (2021-2026) Table 152. Latin America Glycoprotein 41 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Latin America Glycoprotein 41 Market Share Forecast by Country (2027-2032) Table 154. Middle East and Africa Glycoprotein 41 Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 155. Middle East and Africa Glycoprotein 41 Sales by Country (2021-2026) & (W Units) Table 156. Middle East and Africa Glycoprotein 41 Sales Market Share by Country (2021-2026) Table 157. Middle East and Africa Glycoprotein 41 Sales Forecast by Country (2027-2032) & (W Units) Table 158. Middle East and Africa Glycoprotein 41 Sales Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Glycoprotein 41 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Glycoprotein 41 Market Size by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Glycoprotein 41 Market Share by Country (2021-2026) Table 162. Middle East and Africa Glycoprotein 41 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Middle East and Africa Glycoprotein 41 Market Share Forecast by Country (2027-2032) Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Glycoprotein 41 Distributors List Table 167. Glycoprotein 41 Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Glycoprotein 41 Image Figure 2. Global Glycoprotein 41 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glycoprotein 41 Market Size (2021-2032) & (US$ Million) Figure 4. Global Glycoprotein 41 Sales (2021-2032) & (W Units) Figure 5. DS-007 Image Figure 6. Global DS-007 Sales YoY Growth (2021-2032) & (W Units) Figure 7. LBT-5001 Image Figure 8. Global LBT-5001 Sales YoY Growth (2021-2032) & (W Units) Figure 9. LBT-5001 Image Figure 10. Global LBT-5001 Sales YoY Growth (2021-2032) & (W Units) Figure 11. MYMV-101 Image Figure 12. Global MYMV-101 Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Glycoprotein 41 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Glycoprotein 41 Market Share by Type 2025 VS 2032 Figure 17. North America Glycoprotein 41 Sales Market Share in Volume by Type in 2025 Figure 18. North America Glycoprotein 41 Sales Market Share in Value by Type in 2025 Figure 19. Europe Glycoprotein 41 Sales Market Share in Volume by Type in 2025 Figure 20. Europe Glycoprotein 41 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Glycoprotein 41 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Glycoprotein 41 Sales Market Share in Value by Type in 2025 Figure 23. Latin America Glycoprotein 41 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Glycoprotein 41 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Glycoprotein 41 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Glycoprotein 41 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Glycoprotein 41 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital Image Figure 30. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 31. Clinic Image Figure 32. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Glycoprotein 41 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Glycoprotein 41 Market Share by Application 2025 VS 2032 Figure 37. North America Glycoprotein 41 Sales Market Share in Volume by Application in 2025 Figure 38. North America Glycoprotein 41 Sales Market Share in Value by Application in 2025 Figure 39. Europe Glycoprotein 41 Sales Market Share in Volume by Application in 2025 Figure 40. Europe Glycoprotein 41 Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Glycoprotein 41 Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Glycoprotein 41 Sales Market Share in Value by Application in 2025 Figure 43. Latin America Glycoprotein 41 Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Glycoprotein 41 Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Glycoprotein 41 Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Glycoprotein 41 Sales Market Share in Value by Application in 2025 Figure 47. North America Glycoprotein 41 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Glycoprotein 41 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Glycoprotein 41 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Glycoprotein 41 Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Glycoprotein 41 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Glycoprotein 41 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Glycoprotein 41 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Glycoprotein 41 Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Glycoprotein 41 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Glycoprotein 41 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Glycoprotein 41 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Glycoprotein 41 Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Glycoprotein 41 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Glycoprotein 41 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Glycoprotein 41 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Glycoprotein 41 Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Glycoprotein 41 Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Glycoprotein 41 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Glycoprotein 41 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Glycoprotein 41 Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Glycoprotein 41 Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Glycoprotein 41 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • DS-007
  • LBT-5001
  • LBT-5001
  • MYMV-101
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Amunix Operating Inc
  • Frontier Biotechnologies Inc
  • InnaVirVax SA
  • Longevity Biotech Inc
  • Mymetics Corp
  • Navigen Inc
  • Osel Inc
  • Pharis Biotec GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glycoprotein 41 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glycoprotein 41 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glycoprotein 41 Market by Type
  6. 1.3.1 DS-007
  7. 1.3.2 LBT-5001
  8. 1.3.3 LBT-5001
  9. 1.3.4 MYMV-101
  10. 1.3.5 Others
  11. 1.4 Global Glycoprotein 41 Market Size by Type
  12. 1.4.1 Global Glycoprotein 41 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Glycoprotein 41 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Glycoprotein 41 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Glycoprotein 41 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Glycoprotein 41 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Glycoprotein 41 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Glycoprotein 41 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Glycoprotein 41 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glycoprotein 41 Industry Trends
  2. 2.2 Glycoprotein 41 Industry Drivers
  3. 2.3 Glycoprotein 41 Industry Opportunities and Challenges
  4. 2.4 Glycoprotein 41 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glycoprotein 41 Revenue (2021-2026)
  2. 3.2 Global Top Players by Glycoprotein 41 Sales (2021-2026)
  3. 3.3 Global Top Players by Glycoprotein 41 Price (2021-2026)
  4. 3.4 Global Glycoprotein 41 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glycoprotein 41 Major Company Production Sites & Headquarters
  6. 3.6 Global Glycoprotein 41 Company, Product Type & Application
  7. 3.7 Global Glycoprotein 41 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glycoprotein 41 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glycoprotein 41 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glycoprotein 41 Tier 1, Tier 2, and Tier 3
4 Glycoprotein 41 Regional Status and Outlook
  1. 4.1 Global Glycoprotein 41 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glycoprotein 41 Historic Market Size by Region
  3. 4.2.1 Global Glycoprotein 41 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glycoprotein 41 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glycoprotein 41 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glycoprotein 41 Forecasted Market Size by Region
  7. 4.3.1 Global Glycoprotein 41 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glycoprotein 41 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glycoprotein 41 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glycoprotein 41 by Application
  1. 5.1 Glycoprotein 41 Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Glycoprotein 41 Market Size by Application
  6. 5.2.1 Global Glycoprotein 41 Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Glycoprotein 41 Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Glycoprotein 41 Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Glycoprotein 41 Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Glycoprotein 41 Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Glycoprotein 41 Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Glycoprotein 41 Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Glycoprotein 41 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Amunix Operating Inc
  2. 6.1.1 Amunix Operating Inc Company Information
  3. 6.1.2 Amunix Operating Inc Business Overview
  4. 6.1.3 Amunix Operating Inc Glycoprotein 41 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Amunix Operating Inc Glycoprotein 41 Product Portfolio
  6. 6.1.5 Amunix Operating Inc Recent Developments
  7. 6.2 Frontier Biotechnologies Inc
  8. 6.2.1 Frontier Biotechnologies Inc Company Information
  9. 6.2.2 Frontier Biotechnologies Inc Business Overview
  10. 6.2.3 Frontier Biotechnologies Inc Glycoprotein 41 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Frontier Biotechnologies Inc Glycoprotein 41 Product Portfolio
  12. 6.2.5 Frontier Biotechnologies Inc Recent Developments
  13. 6.3 InnaVirVax SA
  14. 6.3.1 InnaVirVax SA Company Information
  15. 6.3.2 InnaVirVax SA Business Overview
  16. 6.3.3 InnaVirVax SA Glycoprotein 41 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 InnaVirVax SA Glycoprotein 41 Product Portfolio
  18. 6.3.5 InnaVirVax SA Recent Developments
  19. 6.4 Longevity Biotech Inc
  20. 6.4.1 Longevity Biotech Inc Company Information
  21. 6.4.2 Longevity Biotech Inc Business Overview
  22. 6.4.3 Longevity Biotech Inc Glycoprotein 41 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Longevity Biotech Inc Glycoprotein 41 Product Portfolio
  24. 6.4.5 Longevity Biotech Inc Recent Developments
  25. 6.5 Mymetics Corp
  26. 6.5.1 Mymetics Corp Company Information
  27. 6.5.2 Mymetics Corp Business Overview
  28. 6.5.3 Mymetics Corp Glycoprotein 41 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mymetics Corp Glycoprotein 41 Product Portfolio
  30. 6.5.5 Mymetics Corp Recent Developments
  31. 6.6 Navigen Inc
  32. 6.6.1 Navigen Inc Company Information
  33. 6.6.2 Navigen Inc Business Overview
  34. 6.6.3 Navigen Inc Glycoprotein 41 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Navigen Inc Glycoprotein 41 Product Portfolio
  36. 6.6.5 Navigen Inc Recent Developments
  37. 6.7 Osel Inc
  38. 6.7.1 Osel Inc Company Information
  39. 6.7.2 Osel Inc Business Overview
  40. 6.7.3 Osel Inc Glycoprotein 41 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Osel Inc Glycoprotein 41 Product Portfolio
  42. 6.7.5 Osel Inc Recent Developments
  43. 6.8 Pharis Biotec GmbH
  44. 6.8.1 Pharis Biotec GmbH Company Information
  45. 6.8.2 Pharis Biotec GmbH Business Overview
  46. 6.8.3 Pharis Biotec GmbH Glycoprotein 41 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pharis Biotec GmbH Glycoprotein 41 Product Portfolio
  48. 6.8.5 Pharis Biotec GmbH Recent Developments
7 North America by Country
  1. 7.1 North America Glycoprotein 41 Sales by Country
  2. 7.1.1 North America Glycoprotein 41 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glycoprotein 41 Sales by Country (2021-2026)
  4. 7.1.3 North America Glycoprotein 41 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glycoprotein 41 Market Size by Country
  6. 7.2.1 North America Glycoprotein 41 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glycoprotein 41 Market Size by Country (2021-2026)
  8. 7.2.3 North America Glycoprotein 41 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glycoprotein 41 Sales by Country
  2. 8.1.1 Europe Glycoprotein 41 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glycoprotein 41 Sales by Country (2021-2026)
  4. 8.1.3 Europe Glycoprotein 41 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glycoprotein 41 Market Size by Country
  6. 8.2.1 Europe Glycoprotein 41 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glycoprotein 41 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glycoprotein 41 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glycoprotein 41 Sales by Country
  2. 9.1.1 Asia-Pacific Glycoprotein 41 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glycoprotein 41 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glycoprotein 41 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glycoprotein 41 Market Size by Country
  6. 9.2.1 Asia-Pacific Glycoprotein 41 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glycoprotein 41 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glycoprotein 41 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glycoprotein 41 Sales by Country
  2. 10.1.1 South America Glycoprotein 41 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glycoprotein 41 Sales by Country (2021-2026)
  4. 10.1.3 South America Glycoprotein 41 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glycoprotein 41 Market Size by Country
  6. 10.2.1 South America Glycoprotein 41 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glycoprotein 41 Market Size by Country (2021-2026)
  8. 10.2.3 South America Glycoprotein 41 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glycoprotein 41 Sales by Country
  2. 11.1.1 Middle East and Africa Glycoprotein 41 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glycoprotein 41 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glycoprotein 41 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glycoprotein 41 Market Size by Country
  6. 11.2.1 Middle East and Africa Glycoprotein 41 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glycoprotein 41 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glycoprotein 41 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glycoprotein 41 Value Chain Analysis
  2. 12.1.1 Glycoprotein 41 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glycoprotein 41 Production Mode & Process
  7. 12.2 Glycoprotein 41 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glycoprotein 41 Distributors
  10. 12.2.3 Glycoprotein 41 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst